Stock listing

NASDAQ:RNA Atrium Therapeutics, Inc. Stock

Home listing (NASDAQ) of Atrium Therapeutics, Inc.

Follow Atrium Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:RNA

$6.92 USD +0.28 (+4.2%)

Close on Nov 20, 2026

Since Feb 27, 2026 -53.1% · daily closes, Feb 27, 2026 – Nov 20, 2026, adjusted for splits
Day range
$6.88 – $7.44 USDNov 20, 2026
Volume
319,656 sharesNov 20, 2026
Market cap
$118.4M USDAt the close on Nov 20, 2026 · price × 17.11M shares outstanding
Traded on an average day
$2.73M USDMedian day 220,812 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Atrium Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RNA · Home$6.92 USD+0.28 (+4.2%)319,656$7.01$7.44$6.875$6.64Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RNA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.92+0.28+4.2%$7.01$7.44$6.875319,656
$6.64+0.16+2.5%$6.46$6.78$6.45220,812
$6.48+0.05+0.8%$6.46$6.945$6.445352,218
$6.43-1.08-14.4%$7.54$7.69$6.36337,582
$7.51+0.01+0.1%$7.71$7.83$7.47195,172
$7.50-0.46-5.8%$7.89$7.89$7.49294,716
$7.96-0.27-3.3%$8.23$8.26$7.93130,118
$8.23-0.15-1.8%$8.30$8.40$8.11108,814
$8.38+0.04+0.5%$8.42$8.463$8.20138,121
$8.34+0.02+0.2%$8.32$8.55$8.23108,189
$8.32-0.36-4.1%$8.68$8.73$8.29193,893
$8.68-0.04-0.5%$8.85$8.99$8.50136,789
$8.72+0.17+2.0%$8.57$8.77$8.45280,927
$8.55+0.28+3.4%$8.22$8.64$8.185470,071
$8.27+0.01+0.1%$8.19$8.31$7.88566,641
$8.26-0.14-1.7%$8.52$8.65$8.20155,777
$8.40+0.08+1.0%$8.14$8.45$8.14233,598
$8.32+0.27+3.4%$8.05$8.39$8.05198,572
$8.05-0.15-1.8%$8.20$8.23$7.98187,418
$8.20+0.04+0.5%$8.06$8.21$7.78192,660
$8.16+0.16+2.0%$8.01$8.185$7.945173,482
$8.00+0.02+0.3%$7.97$8.32$7.96193,208
$7.98+0.37+4.9%$7.75$8.27$7.71289,488
$7.61-0.06-0.8%$7.68$7.87$7.49243,913
$7.67-0.15-1.9%$7.79$8.06$7.67190,978
$7.82+0.14+1.8%$7.75$7.87$7.64131,236
$7.68-0.07-0.9%$7.75$7.935$7.54269,494
$7.75-0.46-5.6%$8.22$8.22$7.75237,187
$8.21-0.19-2.3%$8.40$8.482$8.2187,396
$8.40+0.14+1.7%$8.29$8.50$8.135208,348
$8.26+0.33+4.2%$8.15$8.325$7.965649,309
$7.93-0.06-0.8%$7.95$8.13$7.9391,818
$7.99+0.02+0.3%$8.00$8.07$7.78411,686
$7.97+0.13+1.7%$7.83$8.105$7.63268,285
$7.84-0.30-3.7%$8.22$8.421$7.68533,805
$8.14-0.14-1.7%$8.30$8.44$7.96395,723
$8.28-0.14-1.7%$8.38$8.46$8.22197,306
$8.420.000.0%$8.42$8.50$8.21158,804
$8.42+0.13+1.6%$8.21$8.515$8.05504,915
$8.29+0.10+1.2%$8.20$8.365$8.10221,427
$8.19-0.14-1.7%$8.30$8.49$8.16355,242
$8.33-0.89-9.7%$9.22$9.31$8.29434,524
$9.22+0.03+0.3%$9.24$9.485$9.17241,277
$9.19+0.24+2.7%$8.97$9.34$8.943481,266
$8.95-0.61-6.4%$9.57$9.665$8.661,036,990
$9.56+0.06+0.6%$9.65$9.695$9.435569,619
$9.50-0.59-5.8%$10.11$10.11$9.50356,436
$10.09-0.12-1.2%$10.21$10.21$9.62274,580
$10.21-0.15-1.4%$10.37$10.71$10.15255,714
$10.36+0.01+0.1%$10.37$10.41$10.00247,499
$10.35-0.16-1.5%$10.44$10.74$10.28421,628
$10.51-0.84-7.4%$11.20$11.20$10.34690,444
$11.35-2.84-20.0%$14.08$14.19$10.751,722,578
$14.19-0.41-2.8%$14.51$14.65$14.01167,785
$14.60+0.54+3.8%$14.19$14.68$13.99164,905
$14.06+0.29+2.1%$13.77$14.10$13.76111,641
$13.77+0.45+3.4%$13.24$13.92$13.20178,705
$13.32-0.32-2.3%$13.53$13.55$13.1097,048
$13.64-0.34-2.4%$13.87$13.95$13.51108,637
$13.98+0.13+0.9%$13.78$14.09$13.59120,562
$13.85-0.15-1.1%$13.93$14.07$13.66179,349
$14.00+0.38+2.8%$13.72$14.05$13.41166,578
$13.62+0.42+3.2%$13.27$13.64$13.04140,555
$13.20-0.28-2.1%$13.53$13.59$12.96180,677
$13.48-0.23-1.7%$13.75$13.88$13.20218,806
Ticker
NASDAQ:RNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Atrium Therapeutics, Inc. news

Decks

Atrium Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 139 in all · newest Nov 12, 2026 · oldest 2020
Decks
3 decks · latest Nov 12, 2026

Where Atrium Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RNA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:RNABOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Atrium Therapeutics, Inc.